Metformin for the Treatment of Hidradenitis Suppurativa (HS)

Summary

A randomized controlled trial investigating the metformin is the treatment for hidradenitis suppurativa. Metformin combined with doxycycline will be compared to the standard treatment of doxycycline monotherapy for HS severity and the effect on the pre-diabetic condition.

Timeline

Start

2021-01-25

Primary completion

2023-01-29

Completion

2023-08-23

Drugs

Indications